Drones Take Flight to Disinfect Sports, Entertainment Venues.

DroneLife A Pittsburgh-based drone company has received the FAA’s blessing to use drones to disinfect public venues.
Internet Stock Review, Draganfly

Meet Draganfly (DFLYF) the Tesla of Drones.

A New Leader In The Drone Industry Emerges US Government Bans Chinese Drones Surprise...
draganfly

Goldman Sachs Likes the Drone Industry, and So Do We.

GOLDMAN SACHS INSIGHTS: DRONES SPECIAL REPORT
Steve Wozniak

Adding Draganfly (DFLYF) $1.40 to Watch List.

Amnnounces Deal to Supply 3,000 Drones to Steve Wozniak via 'Woz EDU" Partnership.
Internet Stock Review

Two of Our $5.00 Watch List Stocks Double, in Like Just Five Months!

Added to the Watch List in November, OMNIQ (OMQS) and Galaxy Digital (GLXY) Shine like a Pretty Penny, with OMNIQ Doubling...
OMNIQ

OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...

OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...

Another Look at the Snowflake (SNOW) Mega IPO.

We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245...
OMNIQ

First Zebra (ZBRA) Then Checkpoint (CHKP), OMNIQ (OQMS) Strengthens Product Line-Up.

The Company You Keep.. First, tiny OMNIQ announces a partnership with Zebra (ZBRA) with $4 billion in revenues. And...
Biotech Stock Review

Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.

First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
OMNIQ

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...